Clearview Cancer Institute (CCI) — Huntsville, Alabama

Clearview Cancer Institute (CCI) is a clinical research site located in Huntsville, Alabama, United States 35805.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Clearview Cancer Institute (CCI) has participated in 2 clinical trials.

Therapeutic areas: Carcinoma, Pancreatic Ductal, Stage IV Non-small Cell Lung Cancer.

Sponsors: Sumitomo Pharma America, Inc., Acrotech Biopharma Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clearview Cancer Institute (CCI)?

Clearview Cancer Institute (CCI) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clearview Cancer Institute (CCI) conducted?

Clearview Cancer Institute (CCI) has 2 clinical trials on record. Their work covers Carcinoma, Pancreatic Ductal, Stage IV Non-small Cell Lung Cancer.

Is Clearview Cancer Institute (CCI) accredited by Crixeo Health?

Clearview Cancer Institute (CCI) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clearview Cancer Institute (CCI)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.